Last $117.30 USD
Change Today +0.44 / 0.38%
Volume 1.0M
VRX On Other Exchanges
Symbol
Exchange
Toronto
New York
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Laizer D. Kornwasser

Executive Vice President and Company Group Chairman, Valeant Pharmaceuticals International, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 2 different industries.

See Board Relationships
43$8,813,929
As of Fiscal Year 2013

Background*

Mr. Laizer D. Kornwasser has been Executive Vice President and Company Group Chairman of Valeant Pharmaceuticals International, Inc. since February 1, 2013. Previously, Mr. Kornwasser served as the Senior Vice President of Consumer Solutions and Retail Markets at Medco Health Solutions, Inc. and also served as its Senior Vice President of Retail Mail and Diabetes Markets. Mr. Kornwasser served as Senior Vice President of Channel and Generic Strategy at MedcoHealth Solutions ...

Read Full Background

Corporate Headquarters*

2150 St. Elzéar boulevard West
Laval, Quebec H7L 4A8

Canada

Phone: 514-744-6792
Fax: 514-744-6272

Board Members Memberships*

2008-Present
Director and Member of Compensation Committee

Education*

MBA 1996
Harvard Business School
BS 1992
Yeshiva University

Other Affiliations*

Annual Compensation*

Salary$511,138
Total Annual Compensation$511,138

Stock Options*

Restricted Stock Awards$5,677,305
All Other Compensation$8,695
Unexercisable Options85,000
Unexercisable Options Value$4,230,450
Total Value of Options$4,230,450
Total Number of Options85,000

Total Compensation*

Total Annual Cash Compensation$1,236,794
Total Short Term Compensation$511,138
Other Long Term Compensation$5,686,000
Total Calculated Compensation$8,813,929
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:US $117.30 USD +0.44

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Dilip Shantilal Shanghvi Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee
Sun Pharmaceutical Industries Limited
20.1M
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.